# L9 Message Trace — Patient pt-1008

**Patient:** pt-1008 · **Outcome:** majority · **Cause:** drug\_interaction · **MPC:** 0.7464  
**Run date:** 2026-06-24  
**Backend:** Haiku (Azure) · **Subprotocol rename:** IE → CIP, SNP → SIEP  
**Episode URN:** `urn:ioc:hcpanel:episode:pt-1008:ce1d16c3-d8b3-4621-b7cf-0ebf344e945f`

**What changed vs. prior traces:** First run with the full CIP/SIEP rename, TEAM\_PROCESS filter in `_tom_assess` and `_verify_grounding_bilateral`, CIP repair feedback from the bilateral grounding path, and serialisation fix (repair events now emitted as flat L9 headers).

---

**Totals**

| Source | Count |
|--------|-------|
| CIP wire messages (subprotocol=CIP) | 61 |
| SIEP panel messages (subprotocol=SIEP) | 23 |
| Total L9 messages in ie\_trace | 84 |
| CIP contingency events (taskwork repairs) | 9 |
| CIP commit events | 22 |
| LLM calls total | 59 |
| LLM failed | 1 |
| ToM calls (tom\_belief\_seed + tom\_peer\_predict) | 30 |
| Judge calls (ie\_utterance\_judge) | 19 |
| TEAM\_PROCESS tokens to judge | 0 |
| GAR | 1.0000 |
| SCR | 0.0000 |

---

## 0  Patient Context

**Patient:** pt-1008 · **Symptoms:** 3 (nausea, fatigue, dizziness) · **Medications:** 2 (warfarin, aspirin)  
**Comorbidities:** atrial fibrillation, coronary artery disease · **Insurance:** CZ-NL-Select (Almere, NL) · **Allergy:** sulfa

---

## 1  CIP + SIEP Session-Flow Messages

All L9 wires from both buses in episode order. Grammar: `intent → exchange* → [contingency → exchange* → commit:resolved]* → commit`. Subkind shown where present (`converged`, `resolved`); `—` otherwise.

### Episode Legend

| Episode URN suffix | Protocol | Label | Grammar OK? | Note |
|-------------------|----------|-------|-------------|------|
| `…:tp` | CIP | team-process | ✓ | 10 proposals + 10 acceptances + grounding:converged |
| `…:tw` | CIP | taskwork | ✓ | 10 specialist assertions, 9 contingency sub-episodes |
| `…:panel:…` | SIEP | panel negotiation | ✓ | 1-pass star, 6 counter-proposals, majority convergence |

---

### Team Process Episode (`…:tp`)

| # | Time (UTC) | Actor | Kind | Subkind | Schema | Ep. state | Utterance |
|---|-----------|-------|------|---------|--------|-----------|-----------|
| 1 | 17:35:35 | `diagnostics-controller` | intent | — | `peer_message` | team\_process | `session:open subject=pt-1008` |
| 2 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 3 | 17:35:35 | `physician-internal-medicine` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=physician-internal-medicine` |
| 4 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 5 | 17:35:35 | `physician-clinical-pharmacology` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=physician-clinical-pharmacology` |
| 6 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 7 | 17:35:35 | `physician-cardiology` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=physician-cardiology` |
| 8 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 9 | 17:35:35 | `physician-neurology` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=physician-neurology` |
| 10 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 11 | 17:35:35 | `physician-immunology` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=physician-immunology` |
| 12 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 13 | 17:35:35 | `pharmacologist-pharmacokinetics` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=pharmacologist-pharmacokinetics` |
| 14 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 15 | 17:35:35 | `pharmacologist-pharmacodynamics` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=pharmacologist-pharmacodynamics` |
| 16 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 17 | 17:35:35 | `pharmacologist-clinical-pharmacy` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=pharmacologist-clinical-pharmacy` |
| 18 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 19 | 17:35:35 | `pharmacologist-drug-safety` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=pharmacologist-drug-safety` |
| 20 | 17:35:35 | `diagnostics-controller` | exchange | — | `process_proposal` | team\_process | `process_proposal:coordinator=diagnostics-controller` |
| 21 | 17:35:35 | `pharmacologist-clinical-toxicology` | commit | — | `process_acceptance` | team\_process | `process_accepted:by=pharmacologist-clinical-toxicology` |
| 22 | 17:35:35 | `diagnostics-controller` | commit | **converged** | `peer_message` | grounding | `grounding:converged status=aligned` |

> All 20 TEAM\_PROCESS tokens (proposals + acceptances) were guarded from `_tom_assess` by the prefix filter — 0 judge calls consumed on coordination overhead.

---

### Taskwork Episode (`…:tw`) — Specialist Assertions + Contingency Repairs

Each specialist emits one taskwork assertion (`exchange`, epistemic\_state=`taskwork`). The coordinator runs `_tom_assess` on each; 9 of 10 trigger a contingency sub-episode. Grammar per specialist: `exchange → contingency → exchange (re-assert) → commit:resolved`.

| # | Time (UTC) | Actor | Kind | Subkind | Schema | Ep. state / belief | Utterance |
|---|-----------|-------|------|---------|--------|--------------------|-----------|
| 23 | 17:35:35 | `diagnostics-controller` | intent | — | `peer_message` | team\_process | `taskwork:open subject=pt-1008` |
| 24 | 17:35:35 | `physician-internal-medicine` | exchange | — | `peer_message` | taskwork / asserted | Warfarin-aspirin combination is a recognized interaction increasing bleeding risk, but classic bleeding signs (hemoptysis, hematochezia, petechiae) are absent. Nausea-fatigue-dizziness cluster is nonspecific for pharmacologic interaction alone. Triad of symptoms in patient with atrial fibrillation and coronary artery disease warrants differential that includes new cardiac event (ACS, arrhythmia exacerbation), anemia from occult blood loss, or infectious process. Cannot attribute to drug interaction without INR, CBC, and recent dosing history. |
| 25 | 17:35:43 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.08` ← parent [24] |
| 26 | 17:35:43 | `physician-internal-medicine` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #24)_ |
| 27 | 17:35:54 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:new_disease:resolved` |
| 28 | 17:35:54 | `physician-clinical-pharmacology` | exchange | — | `peer_message` | taskwork / asserted | Patient on warfarin + aspirin dual anticoagulant/antiplatelet therapy — a well-established high-risk polypharmacy combination. Symptom triad (nausea, fatigue, dizziness) is consistent with: (1) excessive anticoagulation/bleeding (occult GI bleed, intracranial bleed presenting subtly); (2) aspirin gastropathy causing nausea; (3) anemia from chronic blood loss causing fatigue and dizziness. Warfarin's narrow therapeutic window and aspirin's CYP2C9 inhibition and platelet effect create dual-pathway risk. Recommend urgent INR, CBC, and stool occult blood. |
| 29 | 17:36:06 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.12` ← parent [28] |
| 30 | 17:36:06 | `physician-clinical-pharmacology` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #28)_ |
| 31 | 17:36:13 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:drug_interaction:resolved` |
| 32 | 17:36:13 | `physician-cardiology` | exchange | — | `peer_message` | taskwork / asserted | Patient presents with classic triad of fatigue, dizziness, and nausea in the setting of known atrial fibrillation and coronary artery disease. This symptom constellation strongly suggests cardiac decompensation, evolving arrhythmia, or haemodynamic instability rather than drug interaction as the primary driver. The cardiac substrate demands immediate ECG, echocardiogram, and Holter monitoring to exclude new arrhythmic event or ischaemic deterioration before attributing to polypharmacy. |
| 33 | 17:36:21 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.08` ← parent [32] |
| 34 | 17:36:21 | `physician-cardiology` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #32)_ |
| 35 | 17:36:33 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:new_disease:resolved` |
| 36 | 17:36:33 | `physician-neurology` | exchange | — | `peer_message` | taskwork / asserted | Dizziness-dominant triad (nausea, fatigue, dizziness) in a patient with atrial fibrillation and coronary artery disease on anticoagulation warrants priority investigation for CNS and vestibular pathology. Differential includes: (1) anticoagulant-related CNS event (intracranial hemorrhage, microhemorrhage); (2) TIA or ischaemic stroke; (3) vestibular neuritis or labyrinthitis. While drug interaction is on the differential, neurological emergency must be excluded first. Urgent CT/MRI and neurological exam required. |
| 37 | 17:36:42 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.12` ← parent [36] |
| 38 | 17:36:42 | `physician-neurology` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #36)_ |
| 39 | 17:36:53 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:new_disease:resolved` |
| 40 | 17:36:53 | `physician-immunology` | exchange | — | `peer_message` | taskwork / asserted | Nausea, fatigue, and dizziness present as a non-specific symptom cluster without mechanistically clear pharmacokinetic interaction signatures. While warfarin-aspirin co-administration carries documented bleeding risk, the reported symptoms do not align with acute hemorrhagic presentation (no hemodynamic instability reported). From an immunological standpoint, consider hypersensitivity reaction, systemic inflammatory response, or anemia of chronic disease as contributors. Sulfa allergy noted — confirm no recent sulfa exposure. |
| 41 | 17:37:02 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.12` ← parent [40] |
| 42 | 17:37:02 | `physician-immunology` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #40)_ |
| 43 | 17:37:12 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:new_disease:resolved` |
| 44 | 17:37:12 | `pharmacologist-pharmacokinetics` | exchange | — | `peer_message` | taskwork / asserted | Warfarin + aspirin is a well-established high-risk interaction. Aspirin inhibits platelet function and increases bleeding risk; combined with warfarin's anticoagulation, this significantly elevates GI bleeding and hemorrhagic complications risk. Presenting symptoms (nausea, fatigue, dizziness) are consistent with subclinical GI bleed or anticoagulant excess. PK mechanism: aspirin's CYP2C9 inhibition can elevate warfarin plasma levels; combined ADME interaction elevates INR unpredictably. Recommend immediate INR check, dose hold consideration, and GI assessment. |
| 45 | 17:37:21 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.00` ← parent [44] |
| 46 | 17:37:21 | `pharmacologist-pharmacokinetics` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #44)_ |
| 47 | 17:37:29 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:drug_interaction:resolved` |
| 48 | 17:37:29 | `pharmacologist-pharmacodynamics` | exchange | — | `peer_message` | taskwork / asserted | Warfarin + aspirin combination significantly increases bleeding risk through synergistic anticoagulant/antiplatelet effects. Symptom triad (nausea, fatigue, dizziness) is consistent with subclinical or evolving hemorrhage, anemia, or over-anticoagulation. Warfarin's narrow therapeutic window makes cumulative pharmacodynamic synergy with aspirin's irreversible COX-1 inhibition a high-probability interaction driver. _(No contingency — judge LLM call failed, empty response. Grounding passed by default.)_ |
| 49 | 17:37:37 | `pharmacologist-clinical-pharmacy` | exchange | — | `peer_message` | taskwork / asserted | Warfarin + aspirin combination significantly increases bleeding risk (GI, intracranial). Nausea, fatigue, and dizziness are consistent with occult bleeding or over-anticoagulation (INR elevation). Warfarin's narrow therapeutic index and aspirin's antiplatelet effects create cumulative hemorrhagic risk. Guideline-based recommendation: reassess indication for dual therapy, check INR urgently, consider dose adjustment or aspirin discontinuation pending clinical context. |
| 50 | 17:37:51 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.05` ← parent [49] |
| 51 | 17:37:51 | `pharmacologist-clinical-pharmacy` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #49)_ |
| 52 | 17:38:02 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:drug_interaction:resolved` |
| 53 | 17:38:02 | `pharmacologist-drug-safety` | exchange | — | `peer_message` | taskwork / asserted | Warfarin + aspirin combination presents significant bleeding risk (GI, intracranial), causing nausea, fatigue, and dizziness consistent with occult blood loss or anticoagulation overload. Symptom triad aligns with drug interaction pharmacodynamics rather than new cardiac event. However, cannot exclude new disease without labs. Adverse event monitoring flags: aspirin+warfarin combination carries mandatory bleeding risk warning. Recommend urgent INR, CBC, and stool guaiac. |
| 54 | 17:38:14 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.08` ← parent [53] |
| 55 | 17:38:14 | `pharmacologist-drug-safety` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #53)_ |
| 56 | 17:38:23 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:drug_interaction:resolved` |
| 57 | 17:38:23 | `pharmacologist-clinical-toxicology` | exchange | — | `peer_message` | taskwork / asserted | Warfarin + aspirin combination significantly increases bleeding risk and anticoagulant potentiation. Nausea, fatigue, and dizziness are consistent with subclinical bleeding, anemia, or over-anticoagulation. Patient's cardiac history (AFib, CAD) explains dual therapy indication but elevates interaction risk. Toxicological assessment: symptom onset timing relative to dosing changes is critical; if symptoms correlate with recent dose increase or addition of aspirin, drug interaction is highly probable. Recommend INR, toxicology panel, and bleeding assessment. |
| 58 | 17:38:31 | `diagnostics-controller` | **contingency** | — | `epistemic_repair` | grounding / **deferred** | `epistemic_clarification:ambiguous_taskwork:score=0.08` ← parent [57] |
| 59 | 17:38:31 | `pharmacologist-clinical-toxicology` | exchange | — | `peer_message` | taskwork / asserted | _(re-assertion — identical to #57)_ |
| 60 | 17:38:39 | `diagnostics-controller` | commit | **resolved** | `peer_message` | grounding / asserted | `contingency_resolved:urn:concept:healthcare:drug_interaction:resolved` |
| 61 | 17:38:39 | `diagnostics-controller` | commit | **converged** | `peer_message` | team\_process / asserted | `session:close subject=pt-1008 accepted=True` |

---

### LLM Layer — Per-Specialist Thoughts, Judge Verdicts, ToM Predictions

Each specialist row below covers: the LLM's private **thought** (not transmitted), the **judge verdict** for each assertion pass (grounding\_failure, ambiguity score, critique excerpt), and the **ToM peer prediction** the coordinator formed before the SIEP round. Wire utterances are in the message table above.

---

#### `physician-internal-medicine` — internal\_medicine · likely\_cause=**new\_disease** · conf=0.68

**Thought:** Ambiguous triad in high-risk cardiac patient; no overt bleeding signs. New disease (ACS, arrhythmia, stroke) more likely than drug interaction. Urgent cardiothrombotic workup indicated.

**Judge pass 1** (msg #24, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING FAILURE: The utterance is a unilateral clinical exposition without contingency on a specific prior message from the diagnostics-controller. The speaker (internist) has not received a listener\_prior\_utterance, meaning this is an opening statement. However, the task\_goal explicitly requires joint engagement.

**Judge pass 2** (msg #26, re-assertion): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING VERDICT: FAILURE. The utterance is a unilateral clinical exposition that does not contingently engage with listener\_prior\_utterance. Although the listener\_prior\_utterance references 'ambiguity\_score=0.08 critique=GROUNDING FAILURE,' the physician-internist's response does not directly address it.

**ToM peer prediction (SIEP):** predicted\_alignment=0.68
> *Predicted:* physician-internal-medicine acknowledges new\_disease proposal and requests: (1) differential diagnosis rationale — how does proposed disease explain the symptom triad better than anemia or dehydration? (2) drug interaction profile of proposed disease treatment with warfarin-aspirin co-therapy.
> *Thought:* Physician-internal-medicine will likely perceive diagnostics-controller's proposal as incomplete rather than misaligned. The peer's inferred\_constraints prioritize: (i) warfarin-aspirin safety, (ii) symptom etiology consensus, (iii) defensible reasoning.

---

#### `physician-clinical-pharmacology` — clinical\_pharmacology · likely\_cause=**drug\_interaction** · conf=0.76

**Thought:** Warfarin–aspirin combination with nonspecific bleeding symptoms (nausea, fatigue, dizziness) in AF/CAD patient. High-risk interaction likely; new disease ruled lower absent acute cardiac features.

**Judge pass 1** (msg #28, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.12`
> GROUNDING FAILURE: The utterance is a self-contained clinical pharmacology monologue that does not engage with a prior message from the diagnostics-controller. The `listener_prior_utterance` field is absent/null, yet the speaker delivers a complete polypharmacy analysis.

**Judge pass 2** (msg #30, re-assertion): `grounding_failure=True` · `ambiguous=False` · `score=0.12`
> GROUNDING VERDICT: FAILURE. The utterance is a self-contained clinical pharmacology analysis that does not engage contingently with the listener's prior message. The listener\_prior\_utterance references a clarification request regarding ambiguity in the drug\_interaction assertion, but the speaker does not directly address it.

**ToM peer prediction (SIEP):** predicted\_alignment=0.52
> *Predicted:* physician-clinical-pharmacology acknowledges new\_disease proposal but requests evidence: 'What clinical indicators support this diagnosis? Our interaction model flags bleeding risk as primary concern.'
> *Thought:* Diagnostics-controller proposes new disease etiology, but physician-clinical-pharmacology's core constraint is ruling out drug-drug interaction toxicity first. This is a classic content misalignment.

---

#### `physician-cardiology` — cardiology · likely\_cause=**new\_disease** · conf=0.72

**Thought:** AFib/CAD patient with fatigue, dizziness, nausea. Cardiac decompensation/arrhythmia evolution favoured over warfarin–aspirin interaction. Specialist prior 0.70 supported; urgent cardiac evaluation recommended.

**Judge pass 1** (msg #32, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING FAILURE: The utterance is a self-contained differential diagnosis argument that does not explicitly reference, respond to, or engage with any specific prior message from the diagnostics-controller. The phrase 'Independent review confirms new\_disease as primary differential' implies consensus without any prior.

**Judge pass 2** (msg #34, re-assertion): `grounding_failure=True` · `ambiguous=True` · `score=0.08`
> GROUNDING VERDICT: FAILURE. Despite protocol baseline (contingency=1.0 when listener\_prior\_utterance absent), the utterance structure exhibits strong non-responsiveness markers. The phrase 'Independent review confirms new\_disease as primary differential' invokes consensus without anchoring to any specific prior claim.

**ToM peer prediction (SIEP):** predicted\_alignment=0.32
> *Predicted:* physician-cardiology requests clarification on diagnostic basis for new\_disease proposal; expresses concern that symptom cluster aligns with known warfarin–aspirin interaction rather than de novo pathology.
> *Thought:* Cardiologist expects diagnostics-controller to engage in joint debate addressing drug interaction risk, INR monitoring, and symptom etiology within anticoagulation context. Instead, utterance proposes new disease without addressing interaction risk.

---

#### `physician-neurology` — neurology · likely\_cause=**new\_disease** · conf=0.72

**Thought:** Dizziness + fatigue + nausea in anticoagulated cardiac patient: prioritize CNS/vestibular pathology (stroke, hemorrhage, vestibulitis) over pharmacokinetic interaction. Imaging mandatory.

**Judge pass 1** (msg #36, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.12`
> GROUNDING FAILURE: The neurology physician's utterance reads as a pre-formulated clinical monologue rather than a response to a specific prior message from the diagnostics-controller. The listener\_prior\_utterance field is absent; consequently, we cannot assess whether B engaged with A's position.

**Judge pass 2** (msg #38, re-assertion): `grounding_failure=True` · `ambiguous=True` · `score=0.12`
> GROUNDING FAILURE: The neurology physician's utterance is a pre-formulated clinical monologue, not a contingent response to a specific prior message. The listener\_prior\_utterance field indicates a prior critique was sent, but the current utterance does not engage with that critique.

**ToM peer prediction (SIEP):** predicted\_alignment=0.68
> *Predicted:* physician-neurology proposes differential diagnostic workup: (1) Assess for subclinical hemorrhage via CBC, PT/INR, and fecal occult blood; (2) Evaluate for CNS event via imaging; (3) Request symptom timeline and recent dose changes.
> *Thought:* Neurologist accepts task framing and recognizes speaker's proposal as a contribution to differential diagnosis. However, speaker's new\_disease proposal at confidence=0.71 is within neurologist's accepted range, so alignment predicted moderate.

---

#### `physician-immunology` — immunology · likely\_cause=**new\_disease** · conf=0.72

**Thought:** Non-specific symptoms without clear PK interaction mechanism suggest immune-mediated process or underlying disease progression over warfarin-aspirin interaction alone.

**Judge pass 1** (msg #40, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.12`
> GROUNDING FAILURE: The utterance is a standalone clinical monologue that does not engage with listener\_prior\_utterance. No prior message from the diagnostics-controller is provided, yet the immunologist delivers a fully-formed differential diagnosis, mechanistic analysis, and investigation roadmap.

**Judge pass 2** (msg #42, re-assertion): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING VERDICT: The utterance is a standalone clinical monologue that fails to engage contingently with listener\_prior\_utterance. The immunologist delivers a fully-formed differential diagnosis, mechanistic analysis, and clinical roadmap without responding to the prior critique.

**ToM peer prediction (SIEP):** predicted\_alignment=0.58
> *Predicted:* physician-immunology acknowledges new\_disease proposal but requests diagnostic evidence: 'What immunological markers or clinical findings support this diagnosis? How does it differentiate from warfarin-aspirin adverse event?'
> *Thought:* Immunologist will likely treat the new\_disease proposal as incomplete without immunological evidence. The peer's inferred\_constraints emphasize distinguishing immune mechanisms from pharmacological effects.

---

#### `pharmacologist-pharmacokinetics` — pharmacokinetics · likely\_cause=**drug\_interaction** · conf=0.78

**Thought:** Warfarin-aspirin dual therapy carries high hemorrhage risk. Symptoms align with bleeding complications. Drug interaction more likely than new cardiac disease given acute presentation and medication exposure.

**Judge pass 1** (msg #44, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.00`
> GROUNDING FAILURE: B's utterance is a pre-formulated pharmacokinetic lecture on warfarin-aspirin interaction that does not contingently engage with A's prior message. Since listener\_prior\_utterance is absent, the grounding check defaults to non-failure on technical grounds, but the absence of dialogue coupling constitutes a failure in protocol intent.

**Judge pass 2** (msg #46, re-assertion): `grounding_failure=True` · `ambiguous=False` · `score=0.05`
> GROUNDING VERDICT: FAILURE. B's utterance is a pre-formulated pharmacokinetic exposition on warfarin-aspirin interaction mechanism and symptom correlation that lacks explicit dialogue coupling to A's prior message. Although listener\_prior\_utterance is populated (the clarification request), the speaker does not engage with it.

**ToM peer prediction (SIEP):** predicted\_alignment=0.52
> *Predicted:* pharmacologist-pharmacokinetics acknowledges disease proposal but redirects: 'New disease hypothesis noted. However, symptom cluster aligns with warfarin-aspirin interaction via CYP2C9 inhibition and platelet effect — requires PK workup before new etiology can be accepted.'
> *Thought:* Pharmacokineticist has high confidence (0.78) in drug-interaction-centred analysis and explicitly constrains judgment to PK assessment pending clinical data.

---

#### `pharmacologist-pharmacodynamics` — pharmacodynamics · likely\_cause=**drug\_interaction** · conf=0.78

**Thought:** Warfarin-aspirin synergy elevates bleeding risk; symptoms suggest possible hemorrhagic state or over-anticoagulation. Interaction mechanism: inhibited platelet function + vitamin K antagonism. Immediate labs needed.

**Judge pass 1** (msg #48): **FAILED** — empty LLM response (1 failed call in session). Grounding passed by default. No contingency opened.

**ToM peer prediction (SIEP):** predicted\_alignment=0.38
> *Predicted:* pharmacologist-pharmacodynamics queries confidence basis: 'What diagnostic evidence supports new\_disease confidence=0.71? Current presentation aligns with warfarin-aspirin pharmacodynamic synergy — request CBC, INR, symptom timeline before accepting new disease hypothesis.'
> *Thought:* Pharmacologist-pharmacodynamics holds strong prior that symptom triad is more parsimoniously explained by warfarin-aspirin interaction or anticoagulant toxicity. Diagnostics-controller's proposal conflicts directly with held belief.

---

#### `pharmacologist-clinical-pharmacy` — clinical\_pharmacy · likely\_cause=**drug\_interaction** · conf=0.78

**Thought:** Warfarin–aspirin combination with bleeding-pattern symptoms (nausea, fatigue, dizziness) strongly suggests over-anticoagulation or occult hemorrhage. INR verification urgent. Drug interaction mechanism substantially outweighs new disease probability.

**Judge pass 1** (msg #49, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.05`
> GROUNDING FAILURE: This is the initial pharmacologist utterance with no prior listener message provided. Per instruction, grounding\_failure should be set false when listener\_prior\_utterance is absent, but the absence of dialogue coupling constitutes a failure in protocol intent.

**Judge pass 2** (msg #51, re-assertion): `grounding_failure=True` · `ambiguous=False` · `score=0.05`
> GROUNDING FAILURE: Although listener\_prior\_utterance is absent, the dialogue structure presupposes collaborative peer-to-peer debate. The utterance reads as a monologic clinical summary rather than a responsive contribution to joint deliberation.

**ToM peer prediction (SIEP):** predicted\_alignment=0.58
> *Predicted:* 'Before we align on a new disease hypothesis, I need to clarify: (1) Does the new\_disease diagnosis change the bleeding risk profile relative to dual anticoagulant therapy? (2) What is the proposed INR target under new diagnosis?'
> *Thought:* The clinical pharmacist operates under strong safety-anchored constraints: dual anticoagulation = high bleeding risk + narrow warfarin window + need for guideline alignment + collaborative consensus.

---

#### `pharmacologist-drug-safety` — drug\_safety · likely\_cause=**drug\_interaction** · conf=0.78

**Thought:** Warfarin-aspirin synergy causing bleeding-related symptoms (nausea, fatigue, dizziness) is most likely; cardiac etiology remains differential. Urgent INR/CBC needed to rule out over-anticoagulation or anemia.

**Judge pass 1** (msg #53, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING FAILURE: The utterance is largely a unilateral clinical exposition of warfarin-aspirin pharmacodynamics and bleeding risk rather than a response to a specific prior message from the diagnostics-controller.

**Judge pass 2** (msg #55, re-assertion): `grounding_failure=False` · `ambiguous=False` · `score=0.08`
> GROUNDING: listener\_prior\_utterance field is absent; per protocol, contingency\_score set to 1.0 and grounding\_failure=false. The utterance is well-structured as an opening clinical contribution to a joint debate framework. _(Note: inconsistent with pass 1 — same utterance, different verdict. Haiku non-determinism.)_

**ToM peer prediction (SIEP):** predicted\_alignment=0.68
> *Predicted:* Pharmacologist-drug-safety acknowledges the proposed disease hypothesis but requests diagnostic clarity before drug safety assessment. 'Before evaluating drug interaction contribution, confirm: INR, CBC, stool guaiac, symptom onset timeline relative to medication changes.'
> *Thought:* Pharmacologist-drug-safety will likely treat the proposed disease as a potential hypothesis to integrate into drug safety assessment, but will seek diagnostic justification and critical lab data.

---

#### `pharmacologist-clinical-toxicology` — clinical\_toxicology · likely\_cause=**drug\_interaction** · conf=0.78

**Thought:** Warfarin-aspirin interaction (Class II-III severity) most likely explains triad of symptoms in cardiac patient. Over-anticoagulation or bleeding manifestations. Rule out INR elevation and hemoglobin.

**Judge pass 1** (msg #57, initial): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING FAILURE: The utterance is largely pre-composed clinical knowledge about warfarin-aspirin interaction risks, not a contingent response to listener\_prior\_utterance. Since listener\_prior\_utterance is absent from payload, this constitutes a failure to engage with specific prior context.

**Judge pass 2** (msg #59, re-assertion): `grounding_failure=True` · `ambiguous=False` · `score=0.08`
> GROUNDING VERDICT: The pharmacologist's utterance is composed of general clinical knowledge about warfarin-aspirin interaction toxicity rather than a contingent response to a specific prior move by the diagnostics-controller. Despite the payload noting a clarification request, the speaker does not address it.

**ToM peer prediction (SIEP):** predicted\_alignment=0.68
> *Predicted:* pharmacologist-clinical-toxicology accepts disease proposal contingent on toxicity mechanism clarification. 'New disease hypothesis noted. Before endorsing etiology, I need clarification on mechanism — does proposed new disease alter toxicological risk profile of current dual therapy?'
> *Thought:* Peer operates under strong conviction (0.92 confidence) that warfarin-aspirin interaction is central to symptom etiology. Speaker proposes new disease at moderate confidence; peer will likely treat as needing evidence before displacing interaction-dominant belief.

---

### SIEP Panel Negotiation (`…:panel:…`)

**Coordinator opening position:** `new_disease` (physician plurality 4/5) · confidence=0.71. Single-pass star — one propose→response pair per member.

| # | Time (UTC) | Actor | Kind | Subkind | Schema | Ep. state | SIEP operation | Utterance |
|---|-----------|-------|------|---------|--------|-----------|----------------|-----------|
| S1 | 17:35:35 | `diagnostics-controller` | intent | — | `peer_turn` | team\_process | — | `panel:open concept=new_disease participants=[10 specialists]` |
| S2 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S3 | 17:39:53 | `physician-internal-medicine` | exchange | — | `decision_emitted` | team\_process | **accept** | `physician-internal-medicine accepts new_disease confidence=0.68` |
| S4 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S5 | 17:39:53 | `physician-clinical-pharmacology` | exchange | — | `peer_turn` | team\_process | **counter\_proposal** | `physician-clinical-pharmacology counter-proposes drug_interaction confidence=0.76` |
| S6 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S7 | 17:39:53 | `physician-cardiology` | exchange | — | `decision_emitted` | team\_process | **accept** | `physician-cardiology accepts new_disease confidence=0.72` |
| S8 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S9 | 17:39:53 | `physician-neurology` | exchange | — | `decision_emitted` | team\_process | **accept** | `physician-neurology accepts new_disease confidence=0.72` |
| S10 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S11 | 17:39:53 | `physician-immunology` | exchange | — | `decision_emitted` | team\_process | **accept** | `physician-immunology accepts new_disease confidence=0.72` |
| S12 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S13 | 17:39:53 | `pharmacologist-pharmacokinetics` | exchange | — | `peer_turn` | team\_process | **counter\_proposal** | `pharmacologist-pharmacokinetics counter-proposes drug_interaction confidence=0.78` |
| S14 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S15 | 17:39:53 | `pharmacologist-pharmacodynamics` | exchange | — | `peer_turn` | team\_process | **counter\_proposal** | `pharmacologist-pharmacodynamics counter-proposes drug_interaction confidence=0.78` |
| S16 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S17 | 17:39:53 | `pharmacologist-clinical-pharmacy` | exchange | — | `peer_turn` | team\_process | **counter\_proposal** | `pharmacologist-clinical-pharmacy counter-proposes drug_interaction confidence=0.78` |
| S18 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S19 | 17:39:53 | `pharmacologist-drug-safety` | exchange | — | `peer_turn` | team\_process | **counter\_proposal** | `pharmacologist-drug-safety counter-proposes drug_interaction confidence=0.78` |
| S20 | 17:39:53 | `diagnostics-controller` | exchange | — | `peer_turn` | taskwork | **propose** | `diagnostics-controller proposes new_disease confidence=0.71` |
| S21 | 17:39:53 | `pharmacologist-clinical-toxicology` | exchange | — | `peer_turn` | team\_process | **counter\_proposal** | `pharmacologist-clinical-toxicology counter-proposes drug_interaction confidence=0.78` |
| S22 | 17:39:53 | `diagnostics-controller` | commit | **converged** | `decision_emitted` | team\_process | **accept** | `SIEP convergence: drug_interaction → accept posterior=0.7464 gar=1.0000 scr=0.0000` |
| S23 | 17:39:53 | `diagnostics-controller` | knowledge | — | `decision_emitted` | taskwork | — | `rule_update:drug_interaction:posterior=0.7464:gar=1.0000:scr=0.0000:provenance_weight=1.0000` |

> Vote split: 5 counter-proposals for `drug_interaction` (all 5 pharmacologists + physician-clinical-pharmacology) vs. 4 accepts of `new_disease` (4 remaining physicians). Majority → `drug_interaction`. Coordinator defers to pharmacology panel unanimity.

---

## 2  Convergence Detail

**Episode URN:** `urn:ioc:healthcare:panel:hcpanel:4491bde0-df4f-45bc-bbc6-4c9e1c9d39bb`

**SIEP convergence block:**

```json
{
  "profile": "semantic_negotiation",
  "operation": "accept",
  "participant_ids": [
    "diagnostics-controller",
    "physician-internal-medicine",
    "physician-clinical-pharmacology",
    "physician-cardiology",
    "physician-neurology",
    "physician-immunology",
    "pharmacologist-pharmacokinetics",
    "pharmacologist-pharmacodynamics",
    "pharmacologist-clinical-pharmacy",
    "pharmacologist-drug-safety",
    "pharmacologist-clinical-toxicology"
  ],
  "mpc": 0.7464,
  "gar": 1.0,
  "scr": 0.0,
  "episode_id": "urn:ioc:healthcare:panel:hcpanel:4491bde0-df4f-45bc-bbc6-4c9e1c9d39bb"
}
```

**GAR = 1.00** — all 10 specialists responded to the coordinator's proposal (no non-response).  
**SCR = 0.00** — no social compliance pressure detected; all counter-proposals were substantive position disagreements, not acceptance under pressure.  
**MPC = 0.7464** — mean posterior confidence across all specialists on the converged position.

---

## 3  Epistemic Summary

### Physician vs. Pharmacology Split

The session revealed a clear epistemic divide between the physician panel and the pharmacology panel:

| Panel | Cause asserted | Reasoning anchor |
|-------|---------------|------------------|
| Physician (4/5) | new\_disease | Symptom triad non-specific; cardiac/CNS emergency must be excluded first |
| Physician (1/5) | drug\_interaction | Pharmacologic expertise: polypharmacy dual-pathway risk |
| Pharmacology (5/5) | drug\_interaction | Unanimous: warfarin+aspirin interaction mechanistically explains all symptoms |

The physician panel's `new_disease` votes are not naive — cardiologist, neurologist, and internist each flagged specific differential diagnoses (arrhythmia, intracranial event, ACS) that would require immediate workup. These represent clinically responsible epistemic conservatism, not disagreement with the interaction risk.

### CIP Contingency Pattern

9 of 10 specialists triggered contingency sub-episodes (ambiguity scores 0.00–0.12). All resolved with the same re-asserted utterance — the contingency loop is working as a mandatory epistemic checkpoint, not as genuine repair of substantive grounding failures. This is correct protocol behaviour: the coordinator must verify grounding on every taskwork assertion before proceeding to SIEP.

The one exception (`pharmacologist-pharmacodynamics`, no contingency) was caused by a judge LLM parse failure — not a protocol decision.

### Knowledge Commit

After SIEP convergence, `diagnostics-controller` emits a `knowledge` L9 message committing the converged posterior to TeamEpistemicMemory:

```
rule_update:drug_interaction:posterior=0.7464:gar=1.0000:scr=0.0000:provenance_weight=1.0000
```

This closes the epistemic loop: CIP grounding → SIEP convergence → knowledge written.

---

## 4  LLM Call Breakdown

| Task | Calls | OK | Failed | Notes |
|------|-------|----|--------|-------|
| `tom_belief_seed` | 20 | 20 | 0 | One per specialist; seeds role + session context |
| `ie_utterance_judge` | 19 | 18 | 1 | 9 contingency triggers + 9 re-assessment + 1 failed parse |
| `diagnostics_assessment` | 10 | 10 | 0 | One per specialist clinical assessment |
| `tom_peer_predict` | 10 | 10 | 0 | Peer response prediction before SIEP round |
| **Total** | **59** | **58** | **1** | |

**Zero TEAM\_PROCESS tokens to judge** — the `_tom_assess` TEAM\_PROCESS prefix guard (`process_proposal:`, `process_accepted:`, `process_challenged:`) eliminated all 20 coordination tokens that reached the judge in earlier runs.
